Cargando…
Diabetes and COVID-19: Short- and Long-Term Consequences
When the corona pandemic commenced more than two years ago, it was quickly recognized that people with metabolic diseases show an augmented risk of severe COVID-19 and an increased mortality compared to people without these comorbidities. Furthermore, an infection with SARS-CoV-2 has been shown to l...
Autores principales: | Steenblock, Charlotte, Hassanein, Mohamed, Khan, Emran G., Yaman, Mohamad, Kamel, Margrit, Barbir, Mahmoud, Lorke, Dietrich E., Rock, John A., Everett, Dean, Bejtullah, Saqipi, Heimerer, Adrian, Tahirukaj, Ermal, Beqiri, Petrit, Bornstein, Stefan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363150/ https://www.ncbi.nlm.nih.gov/pubmed/35724689 http://dx.doi.org/10.1055/a-1878-9566 |
Ejemplares similares
-
Obesity and COVID-19: What are the Consequences?
por: Steenblock, Charlotte, et al.
Publicado: (2022) -
The interface of COVID-19, diabetes, and depression
por: Steenblock, Charlotte, et al.
Publicado: (2022) -
Long-COVID, Metabolic and Endocrine Disease
por: Bornstein, Stefan R., et al.
Publicado: (2022) -
Progress in islet transplantation is more important than ever
por: Bornstein, Stefan R., et al.
Publicado: (2022) -
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
por: Achleitner, Martin, et al.
Publicado: (2023)